GENERIC NAME OF THE MEDICINAL PRODUCT:

A. Telmisartan (IR) + Metoprolol Succinate (ER) Tablets (40mg+50mg)
B. Telmisartan (IR) + Metoprolol Succinate (ER) Tablets (40mg+25mg)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A) Telmisartan (IR) + Metoprolol Succinate (ER) Tablets (40mg+50mg)
Each uncoated bilayered tablet contains:
Telmisartan IP………………………………………40mg
(In immediate release from white coloured layer)
Metoprolol succinate IP
Equivalent to Metoprolol tartrate………..50mg
(In extended-release form yellow coloured layer)
Excipients…………………………………………….q.s

B) Telmisartan (IR) + Metoprolol Succinate (ER) Tablets (40mg+25mg)
Each uncoated bilayered tablet contains:
Telmisartan IP………………………………………40mg
(In immediate release from white coloured layer)
Metoprolol succinate IP
Equivalent to Metoprolol tartrate………..25mg
(In extended-release form yellow coloured layer)
Excipients…………………………………………….q.s

THERAPEUTIC INDICATIONS:

Telmisartan + Metoprolol belongs to the class antihypertensive agents used to treat hypertension (high blood pressure). It may also be used to lower the risk of heart attack and stroke in future.

CAUTION & SCHEDULE:

CAUTION: Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Tablet to be swallowed as a whole, and not to be chewed or crushed.
Reducing salt intake and taking medicines as per doctor’s advice can reduce blood pressure.
SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.

STORAGE & DOSAGE:

Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician

Telmisartan (IR) and Metoprolol Succinate (ER) Tablets (40mg+25mg)  Technical Specification:

Product Name: Telmisartan (IR) + Metoprolol Succinate (ER) Tablets
Brand Name: Generic
Strength: (40mg+50mg), (40mg+25mg)
Dosage Form: Tablets (uncoated)
Route of Administration: Via Oral Route
Packing: 10 Blister strips of 10 Tablets Each
Pack Insert/Leaflet: PIL (Patient Information Leaflet)
Regulatory Documents: COA, MOA, Stability Studies, GMP
Therapeutic use: Antihypertensive
Indication: Telmisartan + Metoprolol belongs to the class antihypertensive agents used to treat hypertension (high blood pressure). It may also be used to lower the risk of heart attack and stroke in future.
Storage: Store at temperature not exceeding 30℃.  Store in cool, dry & dark place. Protect from Light & moisture.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Telmisartan (IR) + Metoprolol Succinate (ER) Tablets (40mg+25mg) 

 QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Telmisartan (IR) + Metoprolol Succinate (ER) Tablets (40mg+25mg)
    Each uncoated Bilayered tablet contains: 
    Telmisartan IP………………………………………40mg
    (In immediate release from white coloured layer) 
    Metoprolol succinate IP
    Equivalent to Metoprolol tartrate………..25mg
    (In extended-release form yellow coloured layer) 
    Excipients…………………………………………….q.s

THERAPEUTIC INDICATIONS:

 Telmisartan + Metoprolol belongs to the class antihypertensive agents used to treat hypertension (high blood pressure). It may also be used to lower the risk of heart attack and stroke in future.

CAUTION & SCHEDULE:

CAUTION:  Read enclosed leaflet before use.
Keep medicine out of reach of children.
Tablet to be swallowed as a whole, and not to be chewed or crushed.
Reducing salt intake and taking medicines as per doctor’s advice can reduce blood pressure.

SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.

STORAGE & DOSAGE:

Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.

Dosage: As directed by the Physician.